Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of simvastatin versus placebo in secondary progressive multiple sclerosis
2017-003328-56Phase 3Unknown
- Sponsor
- University College London Comprehensive Clinical Trials Unit
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in secondary-progressive multiple sclerosis (SPMS) comparing Simvastatin with Placebo (2 arms). Status: unknown.
02
Drugs
simvastatin
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on 2017-003328-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003328-56.